Supplementary material: Evaluation of hypercholesterolemia management in at-risk patients by cardiologists in France: a case vignette-based study

<b>These are peer-reviewed supplementary materials for the article '</b><b>Evaluation of hypercholesterolemia </b><b>management in at-risk patients by </b><b>cardiologists in France: a case </b><b>vignette-based study</b><b>' published in the</b><b> </b><b><i>Journal of Comparative Effectiveness Research</i></b><b>.</b><b>S</b><b>upplementary Figure S1</b><b>Supplementary Figure S2</b><b>Supplementary Table S1</b><b>Supplementary Table S2</b><b>Supplementary Table S3</b><b>Aim: </b>This online interactive survey investigated lipid-lowering approaches of French cardiologists in high and very high-cardiovascular risk patients with hypercholesterolemia. <b>Materials &amp; methods: </b>Physicians assessed three hypothetical patients at three clinic visits, and selected the patients’ cardiovascular risk category, target low-density lipoprotein cholesterol (LDL-C) and treatment. <b>Results: </b>A total of 162 physicians completed 480 risk assessments; 58% of assessments correctly categorized the hypothetical patients. Most physicians chose the correct LDL-C target for one of the very high-risk patients, but higher than recommended targets were selected for the other very high-risk patient and the high-risk patient. Statins were the most commonly chosen treatment. Conclusion: French cardiologists often underestimate cardiovascular risk in patients with hypercholesterolemia, select a higher-than-recommended LDL-C target and prescribe less intensive treatment than that recommended by guidelines.